Impact of the Presence and Proportion of GGO on Survival and Pathological Characteristics in Clinical Stage I Lung Adenocarcinoma

被引：0
|
作者：
Katsumata, S. [1 ]
Aokage, K. [2 ]
Ishii, G. [3 ]
Nakasone, S. [1 ]
Miyoshi, T. [1 ]
Tane, K. [1 ]
Tsuboi, M. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Thorac Surg, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
lung adenocarcinoma; ground-glass opacity; consolidation-to-tumor ratio;
D O I：
10.1016/j.jtho.2019.08.1141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.13-04
引用
收藏
页码：S547 / S547
页数：1
相关论文
共 50 条
  • [41] Effect of clinical stage on survival outcome in patients with pathological stage I gastric cancer.
    Tokunaga, Masanori
    Makuuchi, Rie
    Miki, Yuichiro
    Tanizawa, Yutaka
    Bando, Etsuro
    Kawamura, Taiichi
    Terashima, Masanori
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [42] Prognostic Impact of Preoperative Tumor Marker Levels and Lymphovascular Invasion in Pathological Stage I Adenocarcinoma and Squamous Cell Carcinoma of the Lung
    Kinoshita, Tomonari
    Ohtsuka, Takashi
    Yotsukura, Masaya
    Asakura, Keisuke
    Goto, Taichiro
    Kamiyama, Ikuo
    Otake, Sotaro
    Tajima, Atsushi
    Emoto, Katsura
    Hayashi, Yuichiro
    Kohno, Mitsutomo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (04) : 619 - 628
  • [43] Impact of clinical and pathological variables on stage I non-small cell lung cancer outcomes.
    Lee, Matthew C.
    Stefanov, Dimitre C.
    Angert, Mallorie B.
    Cohn, Erica C.
    Kohn, Nina
    Esposito, Michael J.
    Seetharamu, Nagashree
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma
    Shinya Katsumata
    Keiju Aokage
    Genichiro Ishii
    Hironobu Hoshino
    Jun Suzuki
    Tomohiro Miyoshi
    Kenta Tane
    Joji Samejima
    Masahiro Tsuboi
    Surgery Today, 2021, 51 : 1188 - 1202
  • [45] Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma
    Katsumata, Shinya
    Aokage, Keiju
    Ishii, Genichiro
    Hoshino, Hironobu
    Suzuki, Jun
    Miyoshi, Tomohiro
    Tane, Kenta
    Samejima, Joji
    Tsuboi, Masahiro
    SURGERY TODAY, 2021, 51 (07) : 1188 - 1202
  • [46] Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma
    Jeon, Hyun Woo
    Kim, Young-Du
    Sim, Sung Bo
    Moon, Mi Hyoung
    THORACIC CANCER, 2021, 12 (14) : 2072 - 2077
  • [47] Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma
    Hattori, Aritoshi
    Hirayama, Shunki
    Matsunaga, Takeshi
    Hayashi, Takuo
    Takamochi, Kazuya
    Oh, Shiaki
    Suzuki, Kenji
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (02) : 265 - 275
  • [48] Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma
    Kaseda, Kaoru
    Ishii, Genichiro
    Aokage, Keiju
    Takahashi, Akiko
    Kuwata, Takeshi
    Hishida, Tomoyuki
    Yoshida, Junji
    Kohno, Mitsutomo
    Nagai, Kanji
    Ochiai, Atsushi
    CANCER SCIENCE, 2013, 104 (09): : 1262 - 1269
  • [49] A Modified T Categorization for Pathological Stage I Lung Adenocarcinoma with Lepidic Component in Chinese Population
    Li, S.
    Chen, T.
    Zhao, M.
    Chen, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S522 - S523
  • [50] The Prognostic Impact of KRAS, Its Codon and Amino Acid Specific Mutations, on Survival in Resected Stage I Lung Adenocarcinoma
    Izar, Benjamin
    Zhou, Haiyu
    Heist, Rebecca S.
    Azzoli, Christopher G.
    Muzikansky, Alona
    Scribner, Emily E. F.
    Bernardo, Lindsay A.
    Dias-Santagata, Dora
    Iafrate, Anthony J.
    Lanuti, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : 1363 - 1369
12345